{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:26:06Z","timestamp":1791120366617,"version":"4.1.0"},"reference-count":114,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T00:00:00Z","timestamp":1388448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ovarian carcinoma is the deadliest gynecologic malignancy with very poor rate of survival, and it is characterized by the presence of vast incurable peritoneal metastasis. Studies of the role of chemokine receptors, a family of proteins belonging to the group of G protein-coupled receptors, in ovarian carcinoma strongly placed this family of membrane receptors as major regulators of progression of this malignancy. In this review, we will discuss the roles that chemokine-receptor interactions play to support angiogenesis, cell proliferation, migration, adhesion, invasion, metastasis, and immune evasion in progression of ovarian carcinoma. Data regarding the role that the chemokine receptors play in the disease progression accumulated insofar strongly suggest that this family of proteins could be good therapeutic targets against ovarian carcinoma.<\/jats:p>","DOI":"10.3390\/ijms15010361","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T11:18:16Z","timestamp":1388488696000},"page":"361-376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Chemokine Receptors in Epithelial Ovarian Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Goda","family":"Muralidhar","sequence":"first","affiliation":[{"name":"Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 S Wood Street, PHARM335, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Barbolina","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, University of Illinois at Chicago, 833 S Wood Street, PHARM335, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin"},{"key":"ref_2","unstructured":"(2013). American Cancer Society Cancer Facts & Figures 2013, American Cancer Society."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","article-title":"Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers","volume":"93","author":"Burleson","year":"2004","journal-title":"Gynecol. Oncol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1026519016213","article-title":"CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins","volume":"18","author":"Casey","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1124\/mol.104.009001","article-title":"The repertoire of G-protein-coupled receptors in fully sequenced genomes","volume":"67","author":"Fredriksson","year":"2005","journal-title":"Mol. Pharmacol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygeno.2006.04.001","article-title":"Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse","volume":"88","author":"Gloriam","year":"2006","journal-title":"Genomics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-201X.2007.01693.x","article-title":"Seven transmembrane receptors: Something old, something new","volume":"190","author":"Lefkowitz","year":"2007","journal-title":"Acta Physiol. (Oxf.)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/protein\/7.2.195","article-title":"Fingerprinting G-protein-coupled receptors","volume":"7","author":"Attwood","year":"1994","journal-title":"Protein Eng"},{"key":"ref_12","first-page":"1","article-title":"GCRDb: A G-protein-coupled receptor database","volume":"2","author":"Kolakowski","year":"1994","journal-title":"Recept. Channels"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/pr.57.2.5","article-title":"International Union of Pharmacology. XLVI. G protein-coupled receptor list","volume":"57","author":"Foord","year":"2005","journal-title":"Pharmacol. Rev"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Joost, P., and Methner, A. (2002). Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol, 3.","DOI":"10.1186\/gb-2002-3-11-research0063"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.18388\/abp.2012_2086","article-title":"G protein-coupled receptors\u2014Recent advances","volume":"59","author":"Latek","year":"2012","journal-title":"Acta Biochim. Pol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","article-title":"International union of pharmacology. XXII. Nomenclature for chemokine receptors","volume":"52","author":"Murphy","year":"2000","journal-title":"Pharmacol. Rev"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.bcp.2012.08.008","article-title":"Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors","volume":"84","author":"Szpakowska","year":"2012","journal-title":"Biochem. Pharmacol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jlb.57.5.703","article-title":"Structure-activity relationships of chemokines","volume":"57","author":"Kim","year":"1995","journal-title":"J. Leukoc Biol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.42.091901.115838","article-title":"Structure, function, and inhibition of chemokines","volume":"42","author":"Fernandez","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: A new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00018-011-0677-7","article-title":"The role of chemokines and their receptors in angiogenesis","volume":"68","author":"Kiefer","year":"2011","journal-title":"Cell Mol. Life Sci"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1093\/emboj\/16.23.6996","article-title":"Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1","volume":"16","author":"Crump","year":"1997","journal-title":"EMBO J"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1074\/jbc.271.32.19084","article-title":"The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES\/MIP-1alpha receptor, confers chemokine selectivity. Evidence for a two-step mechanism for MCP-1 receptor activation","volume":"271","author":"Monteclaro","year":"1996","journal-title":"J. Biol. Chem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.yexcr.2011.01.005","article-title":"Chemokines in health and disease","volume":"317","author":"Raman","year":"2011","journal-title":"Exp. Cell Res"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1242\/jcs.039057","article-title":"VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis","volume":"122","author":"Neel","year":"2009","journal-title":"J. Cell Sci"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0076-6879(09)05215-X","article-title":"Characterization of chemokine receptor CXCR2 interacting proteins using a proteomics approach to define the CXCR2 \u201cchemosynapse\u201d","volume":"460","author":"Raman","year":"2009","journal-title":"Methods Enzymol"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e10050","DOI":"10.1371\/journal.pone.0010050","article-title":"LIM and SH3 protein-1 modulates CXCR2-mediated cell migration","volume":"5","author":"Raman","year":"2010","journal-title":"PLoS One"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14489","DOI":"10.1073\/pnas.94.26.14489","article-title":"Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs","volume":"94","author":"Neptune","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nri2972","article-title":"Overcoming hurdles in developing successful drugs targeting chemokine receptors","volume":"11","author":"Schall","year":"2011","journal-title":"Nat. Rev. Immunol"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cytogfr.2005.05.005","article-title":"Dimerization of chemokine receptors and its functional consequences","volume":"16","author":"Springael","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/emboj\/20.10.2497","article-title":"Chemokine receptor homo- or heterodimerization activates distinct signaling pathways","volume":"20","author":"Mellado","year":"2001","journal-title":"EMBO J"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur. J. Pharmacol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1074\/jbc.M405364200","article-title":"Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level","volume":"280","author":"Nesmelova","year":"2005","journal-title":"J. Biol. Chem"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1196\/annals.1329.021","article-title":"CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line","volume":"1030","author":"Porcile","year":"2004","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.yexcr.2005.04.024","article-title":"Stromal cell-derived factor-1alpha (SDF-1alpha\/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation","volume":"308","author":"Porcile","year":"2005","journal-title":"Exp. Cell. Res"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15885","DOI":"10.3390\/ijms140815885","article-title":"Angiogenesis-related pathways in the pathogenesis of ovarian cancer","volume":"14","author":"Gavalas","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1158\/1541-7786.MCR-12-0353","article-title":"Revisiting the complexity of the ovarian cancer microenvironment\u2014Clinical implications for treatment strategies","volume":"10","author":"Musrap","year":"2012","journal-title":"Mol. Cancer Res"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.critrevonc.2012.04.002","article-title":"Angiogenesis: A promising therapeutic target for ovarian cancer","volume":"84","author":"Bamias","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.99-0963com","article-title":"Differential expression and responsiveness of chemokine receptors (CXCR1\u20133) by human microvascular endothelial cells and umbilical vein endothelial cells","volume":"14","author":"Salcedo","year":"2000","journal-title":"FASEB J"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/0008-5472.CAN-09-4341","article-title":"Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: Implications for antiangiogenic therapy","volume":"70","author":"Agarwal","year":"2010","journal-title":"Cancer Res"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2005.12.011","article-title":"Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer","volume":"102","author":"Lokshin","year":"2006","journal-title":"Gynecol. Oncol"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/djn024","article-title":"Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth","volume":"100","author":"Merritt","year":"2008","journal-title":"J. Natl. Cancer Inst"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-10-0483","article-title":"CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis","volume":"16","author":"Yang","year":"2010","journal-title":"Clin. Cancer Res"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/0008-5472.465.65.2","article-title":"CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers","volume":"65","author":"Kryczek","year":"2005","journal-title":"Cancer Res"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","article-title":"CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer","volume":"71","author":"Righi","year":"2011","journal-title":"Cancer Res"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.cji.0000211324.53396.f6","article-title":"Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs, role in the inflammatory response within tumors","volume":"30","author":"Lotfi","year":"2007","journal-title":"J. Immunother"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0092-8674(00)80856-9","article-title":"Regulatory T cells: Key controllers of immunologic self-tolerance","volume":"101","author":"Sakaguchi","year":"2000","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Burleson","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Davidowitz, R.A., Iwanicki, M.P., and Brugge, J.S. (2012). In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. J. Vis. Exp.","DOI":"10.3791\/3888"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1541-7786.MCR-11-0256","article-title":"Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/385640a0","article-title":"A new class of membrane-bound chemokine with a CX3C motif","volume":"385","author":"Bazan","year":"1997","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e21546","DOI":"10.1371\/journal.pone.0021546","article-title":"Identification of the chemokine CX3CL1 as a new regulator of malignant cell proliferation in epithelial ovarian cancer","volume":"6","author":"Gaudin","year":"2011","journal-title":"PLoS One"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1158\/1541-7786.MCR-12-0361","article-title":"The lymphotactin receptor is expressed in epithelial ovarian carcinoma and contributes to cell migration and proliferation","volume":"10","author":"Kim","year":"2012","journal-title":"Mol. Cancer Res"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","article-title":"Microenvironmental regulation of metastasis","volume":"9","author":"Joyce","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/path.4258","article-title":"Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts","volume":"232","author":"Lau","year":"2013","journal-title":"J. Pathol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu. Rev. Pathol"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1038\/onc.2011.653","article-title":"Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium","volume":"31","author":"Archibald","year":"2012","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5732\/cjc.010.10490","article-title":"Chemokine axes CXCL12\/CXCR4 and CXCL16\/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma","volume":"30","author":"Guo","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2007.05.013","article-title":"The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells","volume":"60","author":"Guo","year":"2007","journal-title":"Colloids Surf. B"},{"key":"ref_66","first-page":"4961","article-title":"Epithelial cancer cell migration: A role for chemokine receptors?","volume":"61","author":"Scotton","year":"2001","journal-title":"Cancer Res"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3892\/or.2011.1596","article-title":"Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression","volume":"27","author":"Sheng","year":"2012","journal-title":"Oncol. Rep"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-013-1671-1","article-title":"Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by \u03b1v\u03b26 integrin-mediated signaling in ovarian cancer","volume":"380","author":"Xue","year":"2013","journal-title":"Mol. Cell Biochem"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1541-7786.MCR-09-0463","article-title":"Microenvironmental regulation of chemokine (C-X-C-motif) receptor 4 in ovarian carcinoma","volume":"8","author":"Barbolina","year":"2010","journal-title":"Mol. Cancer Res"},{"key":"ref_70","first-page":"5930","article-title":"Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer","volume":"62","author":"Scotton","year":"2002","journal-title":"Cancer Res"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2010.11.007","article-title":"Involvement of autocrine CXCL12\/CXCR4 system in the regulation of ovarian carcinoma cell invasion","volume":"403","author":"Miyanishi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-\u03baB-mediated MMP-9 upregulation","volume":"30","author":"Long","year":"2012","journal-title":"Stem Cells"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ijc.23083","article-title":"Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma","volume":"122","author":"Kajiyama","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1535-7163.MCT-08-0966","article-title":"An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells","volume":"8","author":"Kwong","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"J. Biol. Chem"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"ref_77","first-page":"1","article-title":"Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients","volume":"13","author":"Wang","year":"2013","journal-title":"Cancer Immun"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-011-9289-9","article-title":"Tumor immune surveillance and ovarian cancer: Lessons on immune mediated tumor rejection or tolerance","volume":"30","author":"Kandalaft","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"226","DOI":"10.18632\/oncotarget.478","article-title":"Double agents in the war on cancer: Leukocytes govern ovarian cancer progression","volume":"3","author":"Scarlett","year":"2012","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0889-8588(03)00064-9","article-title":"Immunologic principles and immunotherapeutic approaches in ovarian cancer","volume":"17","author":"Knutson","year":"2003","journal-title":"Hematol. Oncol. Clin. N. Am"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/imt.11.20","article-title":"Immunity and immune suppression in human ovarian cancer","volume":"3","author":"Preston","year":"2011","journal-title":"Immunotherapy"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2010.01.019","article-title":"Ovarian cancer creates a suppressive microenvironment to escape immune elimination","volume":"117","author":"Yigit","year":"2010","journal-title":"Gynecol. Oncol"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ijc.27759","article-title":"Dynamics of T-cell infiltration during the course of ovarian cancer: The gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells","volume":"132","author":"Sojka","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1158\/0008-5472.CAN-12-0579","article-title":"CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity","volume":"72","author":"Redjimi","year":"2012","journal-title":"Cancer Res"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-04-4043","article-title":"Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma","volume":"65","author":"Wei","year":"2005","journal-title":"Cancer Res"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1006\/cyto.1996.0077","article-title":"A cytokine profile of normal and malignant ovary","volume":"8","author":"Burke","year":"1996","journal-title":"Cytokine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI117933","article-title":"The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer","volume":"95","author":"Negus","year":"1995","journal-title":"J. Clin. Invest"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4049\/jimmunol.164.2.733","article-title":"Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma","volume":"164","author":"Sica","year":"2000","journal-title":"J. Immunol"},{"key":"ref_90","first-page":"4785","article-title":"MCP-1 promotes invasion and adhesion of human ovarian cancer cells","volume":"33","author":"Furukawa","year":"2013","journal-title":"Anticancer Res"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1470-2045(03)01196-3","article-title":"Tumour necrosis factor alpha: A potential target for the therapy of solid tumours","volume":"4","author":"Szlosarek","year":"2003","journal-title":"Lancet Oncol"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1158\/0008-5472.CAN-05-0957","article-title":"The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells","volume":"65","author":"Kulbe","year":"2005","journal-title":"Cancer Res"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/nm1201-1339","article-title":"Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells","volume":"7","author":"Zou","year":"2001","journal-title":"Nat. Med"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1593\/neo.09228","article-title":"Phenotypic and functional delineation of murine CX(3)CR1 monocyte-derived cells in ovarian cancer","volume":"11","author":"Hart","year":"2009","journal-title":"Neoplasia"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1158\/0008-5472.CAN-12-4366","article-title":"IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment","volume":"73","author":"Wong","year":"2013","journal-title":"Cancer Res"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1158\/0008-5472.CAN-08-4329","article-title":"CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion","volume":"69","author":"Nesbeth","year":"2009","journal-title":"Cancer Res"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.2174\/13816128112092432","article-title":"Molecular mechanisms of pancreatic cancer dissemination: The role of the chemokine system","volume":"18","author":"Marchesi","year":"2012","journal-title":"Curr. Pharm. Des"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annu. Rev. Immunol"},{"key":"ref_100","first-page":"335","article-title":"Chemokines and renal inflammation","volume":"20","author":"Panzer","year":"1999","journal-title":"Nephrologie"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1034\/j.1600-065X.2000.17721.x","article-title":"The strategy of blocking the chemokine system to combat disease","volume":"177","author":"Proudfoot","year":"2000","journal-title":"Immunol. Rev"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.06.008","article-title":"Targeting chemokine receptors in chronic inflammatory diseases: An extensive review","volume":"133","author":"Koelink","year":"2012","journal-title":"Pharmacol. Ther"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/138945006775270204","article-title":"Asthma, allergy and chemokines","volume":"7","author":"Pease","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.addr.2006.03.012","article-title":"The chemokine network: A target in cancer biology?","volume":"58","author":"Slettenaar","year":"2006","journal-title":"Adv. Drug Deliv. Rev"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0165-6147(98)01247-4","article-title":"Definition, function and pathophysiological significance of chemokine receptors","volume":"19","author":"Wells","year":"1998","journal-title":"Trends Pharmacol. Sci"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1021\/jm300682j","article-title":"Chemokine receptor antagonists","volume":"55","author":"Pease","year":"2012","journal-title":"J. Med. Chem"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1086\/589289","article-title":"Reviews of anti-infective agents: Maraviroc: The first of a new class of antiretroviral agents","volume":"47","author":"MacArthur","year":"2008","journal-title":"Clin. Infect. Dis"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bcp.2008.12.014","article-title":"The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)","volume":"77","year":"2009","journal-title":"Biochem. Pharmacol"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000315736","article-title":"FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation","volume":"78","author":"Brave","year":"2010","journal-title":"Oncology"},{"key":"ref_110","unstructured":"Available online: http:\/\/clinicaltrials.gov\/show\/NCT00920790."},{"key":"ref_111","unstructured":"Available online: http:\/\/clinicaltrials.gov\/show\/NCT01611142."},{"key":"ref_112","unstructured":"Available online: http:\/\/clinicaltrials.gov\/show\/NCT01010880."},{"key":"ref_113","unstructured":"Available online: http:\/\/clinicaltrials.gov\/show\/NCT00851955."},{"key":"ref_114","unstructured":"Available online: http:\/\/clinicaltrials.gov\/show\/NCT00174096."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/1\/361\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:51:46Z","timestamp":1760219506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/15\/1\/361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,31]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1]]}},"alternative-id":["ijms15010361"],"URL":"https:\/\/doi.org\/10.3390\/ijms15010361","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,31]]}}}